Randomized prospective double-blind studies to evaluate the cognitive effects of inositol-stabilized arginine silicate in healthy physically active adults

Douglas Kalman, Philip D Harvey, Sara Perez Ojalvo, James Komorowski

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Inositol-stabilized arginine silicate (ASI; Nitrosigine®) has been validated to increase levels of arginine, silicon and nitric oxide production. To evaluate potential enhancement of mental focus and clarity, ASI (1500 mg/day) was tested in two double-blind placebo-controlled crossover (DBPC-X) studies using the Trail Making Test (TMT, Parts A and B). In the two studies, healthy males took ASI for 14 and 3 days, respectively. In the first study, after 14 days of dosing, TMT B time decreased significantly from baseline (28% improvement, p = 0.045). In the second study evaluating shorter-term effects, TMT B time decreased significantly compared to placebo (33% improvement, p = 0.024) in a 10-min period. After 3 days of dosing, TMT B time significantly decreased from baseline scores (35% improvement, p < 0.001). These findings show that ASI significantly improved the ability to perform complex cognitive tests requiring mental flexibility, processing speed and executive functioning.

Original languageEnglish (US)
Article number736
JournalNutrients
Volume8
Issue number11
DOIs
StatePublished - Nov 18 2016

Fingerprint

Silicates
Inositol
silicates
Double-Blind Method
placebos
arginine
Arginine
silicon
Placebos
Trail Making Test
nitric oxide
Intelligence Tests
Aptitude
testing
Silicon
Nitric Oxide
inositols

Keywords

  • Cognitive function
  • L-arginine
  • Mental flexibility
  • Nitric oxide
  • Silicate

ASJC Scopus subject areas

  • Food Science

Cite this

Randomized prospective double-blind studies to evaluate the cognitive effects of inositol-stabilized arginine silicate in healthy physically active adults. / Kalman, Douglas; Harvey, Philip D; Ojalvo, Sara Perez; Komorowski, James.

In: Nutrients, Vol. 8, No. 11, 736, 18.11.2016.

Research output: Contribution to journalArticle

@article{179190592da04e9496b56ab03d04ce3f,
title = "Randomized prospective double-blind studies to evaluate the cognitive effects of inositol-stabilized arginine silicate in healthy physically active adults",
abstract = "Inositol-stabilized arginine silicate (ASI; Nitrosigine{\circledR}) has been validated to increase levels of arginine, silicon and nitric oxide production. To evaluate potential enhancement of mental focus and clarity, ASI (1500 mg/day) was tested in two double-blind placebo-controlled crossover (DBPC-X) studies using the Trail Making Test (TMT, Parts A and B). In the two studies, healthy males took ASI for 14 and 3 days, respectively. In the first study, after 14 days of dosing, TMT B time decreased significantly from baseline (28{\%} improvement, p = 0.045). In the second study evaluating shorter-term effects, TMT B time decreased significantly compared to placebo (33{\%} improvement, p = 0.024) in a 10-min period. After 3 days of dosing, TMT B time significantly decreased from baseline scores (35{\%} improvement, p < 0.001). These findings show that ASI significantly improved the ability to perform complex cognitive tests requiring mental flexibility, processing speed and executive functioning.",
keywords = "Cognitive function, L-arginine, Mental flexibility, Nitric oxide, Silicate",
author = "Douglas Kalman and Harvey, {Philip D} and Ojalvo, {Sara Perez} and James Komorowski",
year = "2016",
month = "11",
day = "18",
doi = "10.3390/nu8110736",
language = "English (US)",
volume = "8",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "11",

}

TY - JOUR

T1 - Randomized prospective double-blind studies to evaluate the cognitive effects of inositol-stabilized arginine silicate in healthy physically active adults

AU - Kalman, Douglas

AU - Harvey, Philip D

AU - Ojalvo, Sara Perez

AU - Komorowski, James

PY - 2016/11/18

Y1 - 2016/11/18

N2 - Inositol-stabilized arginine silicate (ASI; Nitrosigine®) has been validated to increase levels of arginine, silicon and nitric oxide production. To evaluate potential enhancement of mental focus and clarity, ASI (1500 mg/day) was tested in two double-blind placebo-controlled crossover (DBPC-X) studies using the Trail Making Test (TMT, Parts A and B). In the two studies, healthy males took ASI for 14 and 3 days, respectively. In the first study, after 14 days of dosing, TMT B time decreased significantly from baseline (28% improvement, p = 0.045). In the second study evaluating shorter-term effects, TMT B time decreased significantly compared to placebo (33% improvement, p = 0.024) in a 10-min period. After 3 days of dosing, TMT B time significantly decreased from baseline scores (35% improvement, p < 0.001). These findings show that ASI significantly improved the ability to perform complex cognitive tests requiring mental flexibility, processing speed and executive functioning.

AB - Inositol-stabilized arginine silicate (ASI; Nitrosigine®) has been validated to increase levels of arginine, silicon and nitric oxide production. To evaluate potential enhancement of mental focus and clarity, ASI (1500 mg/day) was tested in two double-blind placebo-controlled crossover (DBPC-X) studies using the Trail Making Test (TMT, Parts A and B). In the two studies, healthy males took ASI for 14 and 3 days, respectively. In the first study, after 14 days of dosing, TMT B time decreased significantly from baseline (28% improvement, p = 0.045). In the second study evaluating shorter-term effects, TMT B time decreased significantly compared to placebo (33% improvement, p = 0.024) in a 10-min period. After 3 days of dosing, TMT B time significantly decreased from baseline scores (35% improvement, p < 0.001). These findings show that ASI significantly improved the ability to perform complex cognitive tests requiring mental flexibility, processing speed and executive functioning.

KW - Cognitive function

KW - L-arginine

KW - Mental flexibility

KW - Nitric oxide

KW - Silicate

UR - http://www.scopus.com/inward/record.url?scp=84996486569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996486569&partnerID=8YFLogxK

U2 - 10.3390/nu8110736

DO - 10.3390/nu8110736

M3 - Article

C2 - 27869715

AN - SCOPUS:84996486569

VL - 8

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 11

M1 - 736

ER -